Retatrutide (5 mg Vial)

This reference covers Retatrutide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Retatrutide (5 mg Vial)

Synonyms/Alias: Retatrutide

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

This reference covers Retatrutide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Quickstart

Reconstitute: Add 1.0 mL bacteriostatic water β†’ ~ 5.0 mg/mL concentration.

Typical weekly range: 2–8 mg once weekly (gradual escalation over 8–12 weeks).

Easy measuring: At 5.0 mg/mL, 1 unit = 0.01 mL β‰ˆ 50 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) for up to 4 weeks.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [14]. Rotate injection sites (abdomen, thighs, upper arms) systematically to reduce local irritation and lipohypertrophy [13]. For doses >5 mg with 1.0 mL reconstitution, prepare multiple vials to obtain the required volume. For volumes >1.0 mL, split into 2–3 separate injections at different sites for better absorption [5]. Inject slowly; wait a few seconds before withdrawing the needle to ensure full dose delivery. Document weekly dose, date, and injectio

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–4
Weekly Dose: 2 mg (2000 mcg) | Units (per injection) (mL): 40 units (0.40 mL) | Vials Needed: 1 vial per dose
Weeks 5–8
Weekly Dose: 4 mg (4000 mcg) | Units (per injection) (mL): 80 units (0.80 mL) | Vials Needed: 1 vial per dose
Weeks 9–12
Weekly Dose: 6 mg (6000 mcg) | Units (per injection) (mL): 120 units (1.20 mL) | Vials Needed: 2 vials per dose**
Weeks 13+
Weekly Dose: 8 mg (8000 mcg) | Units (per injection) (mL): 160 units (1.60 mL) | Vials Needed: 2 vials per dose**
Long-term Storage Conditions
Lyophilized: freeze at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) for up to 4 weeks.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Retatrutide, 5 mg each): 12 weeks (Standard to 6 mg): 10 vials

24 weeks (Standard to 8 mg): 29 vials

12 weeks (Aggressive to 8 mg): 12 vials

Insulin Syringes (U-100, 1 mL capacity): Per week: 1–3 syringes (depending on dose; higher doses require split injections)

12 weeks: 12–36 syringes

24 weeks: 24–72 syringes

Bacteriostatic Water (10 mL bottles): Use ~1.0 mL per vial for reconstitution. 12 weeks (10 vials): 10 mL β†’ 1 Γ— 10 mL bottle

24 weeks (29 vials): 29 mL β†’ 3 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for each injection site. Per week: 4–8 swabs (1–3 per vial + 1–3 per injection site)

12 weeks: ~75 swabs β†’ recommend 1 Γ— 100-count box

24 weeks: ~150 swabs β†’ recommend 2 Γ— 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services